Gilead Sciences Aktie
WKN: 885823 / ISIN: US3755581036
|
10.02.2026 23:30:09
|
Gilead Sciences Inc. Q4 Profit Advances
(RTTNews) - Gilead Sciences Inc. (GILD) released earnings for its fourth quarter that Increases, from the same period last year
The company's bottom line totaled $2.183 billion, or $1.74 per share. This compares with $1.783 billion, or $1.42 per share, last year.
Excluding items, Gilead Sciences Inc. reported adjusted earnings of $2.329 billion or $1.86 per share for the period.
The company's revenue for the period rose 4.7% to $7.925 billion from $7.569 billion last year.
Gilead Sciences Inc. earnings at a glance (GAAP) :
-Earnings: $2.183 Bln. vs. $1.783 Bln. last year. -EPS: $1.74 vs. $1.42 last year. -Revenue: $7.925 Bln vs. $7.569 Bln last year.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Gilead Sciences Inc.
Analysen zu Gilead Sciences Inc.
Aktien in diesem Artikel
| Gilead Sciences Inc. | 121,24 | 0,61% |
|